Anhui Medical University, Hefei, Anhui Province, 230022, China.
Department of Critical Care Medicine, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, Anhui Province, 241000, China.
BMC Pulm Med. 2024 Nov 14;24(1):568. doi: 10.1186/s12890-024-03379-x.
Acetaminophen is a commonly used analgesic after surgery, and its impact on prognosis in patients with acute respiratory distress syndrome (ARDS) has not been studied. This study explores the association between the use of acetaminophen and the risk of mortality in patients with ARDS.
In this retrospective cohort study, 3,227 patients with ARDS who had or had not received acetaminophen were obtained from the Medical Information Mart for Intensive Care IV, patients were divided into acetaminophen and non- acetaminophen groups. In-hospital mortality of ARDS patients was considered as primary end point. We used univariate and multivariate Cox regression analyses to assess the relationship of acetaminophen use and in-hospital mortality in patients with ARDS. Subgroup analysis was performed according to age, gender, and severity of ARDS.
Of the total patients, 2,438 individuals were identified as acetaminophen users. The median duration of follow-up was 10.54 (5.57, 18.82) days. The results showed that the acetaminophen use was associated with a decreased risk of in-hospital mortality [hazard ratio (HR) = 0.67, 95% confidence interval (CI): 0.57-0.78]. Across various subgroups of patients with ARDS based on age, gender, and severity, acetaminophen use exhibited an association with reduced risk of in-hospital mortality.
Acetaminophen use was associated with in-hospital mortality of patients with ARDS. Acetaminophen therapy may represent a promising therapeutic option for ARDS patients and warrants further investigation.
扑热息痛是手术后常用的镇痛药,但其对急性呼吸窘迫综合征(ARDS)患者预后的影响尚未研究。本研究探讨了扑热息痛的使用与 ARDS 患者死亡风险之间的关系。
在这项回顾性队列研究中,我们从医疗信息共享数据库中获取了 3227 名接受或未接受扑热息痛治疗的 ARDS 患者,将患者分为扑热息痛组和非扑热息痛组。将 ARDS 患者的院内死亡率作为主要终点。我们使用单变量和多变量 Cox 回归分析评估 ARDS 患者扑热息痛使用与院内死亡率的关系。根据年龄、性别和 ARDS 严重程度进行亚组分析。
在所有患者中,有 2438 名患者被确定为扑热息痛使用者。中位随访时间为 10.54(5.57,18.82)天。结果表明,扑热息痛的使用与降低院内死亡率相关[风险比(HR)=0.67,95%置信区间(CI):0.57-0.78]。在基于年龄、性别和严重程度的各种 ARDS 患者亚组中,扑热息痛的使用均与降低院内死亡率相关。
扑热息痛的使用与 ARDS 患者的院内死亡率相关。扑热息痛治疗可能是 ARDS 患者有前途的治疗选择,值得进一步研究。